External quality assessment on detection of hepatitis C virus RNA in clinical laboratories of China

• Published in: Chinese medical journal 2008-06, Vol.121 (11), p.1032-1036
• Main Authors: Wang, Lu-nan, Zhang, Rui, Shen, Zi-yu, Chen, Wen-xiang, Li, Jin-ming
• Format: Article
• Language: English
• Subjects: Hepacivirus - genetics; Humans; Laboratories - standards; Polymerase Chain Reaction; Quality Control; Reagent Kits, Diagnostic; RNA, Viral - analysis; 丙型肝炎病毒; 临床实验; 聚合酶链反应
• ISSN: 0366-6999; 2542-5641
• DOI: 10.1097/00029330-200806010-00013

Background As with many studies carried out in European countries, a quality assurance program has been established by the National Center for Clinical Laboratories in China （NCCL）. The results showed that the external quality assessment significantly improves laboratory performance for quantitative evaluation of hepatitis C virus （HCV） RNA. Methods Serum panels were delivered twice annually to the clinical laboratories which performed HCV RNA detection in China. Each panel made up of 5 coded samples. All laboratories were requested to carry out the detection within the required time period and report on testing results which contained qualitative and/or quantitative test findings, reagents used and relevant information about apparatus. All the positive samples were calibrated against the first International Standard for HCV RNA in a collaborative study and the range of comparison target value （TG） designated as ±0.5 log. Results The numbers of laboratories reporting on qualitative testing results for the first and second time external quality assessment were 168 and 167 in the year of 2003 and increased to 209 and 233 in 2007; the numbers of laboratories reporting on quantitative testing results were 134 and 147 in 2003 and rose to 340 and 339 in 2007. Deviation between the mean value for quantitative results at home in 2003 and the target value was above 0.5 log, which was comparatively high. By 2007, the target value was close to the national average except for the low concentrated specimens （10^3 IU/ml）. The percentage of results within the range of GM±0.5 log10 varied from 8.2% to 93.5%. Some laboratories had some difficulties in the exact quantification of the lowest （3.00 log IU/ml） as well as of the highest viral levels （6.37 log IU/ml） values, very near to the limits of the dynamic range of the assays. Conclusions The comparison of these results with the previous study confirms that a regular participation in external quality assessment （EQA） assures the achievement of a high proficiency level in the diagnosis of HCV infection. During the 5-year external quality assessment, sensitivity and accuracy of detection in most of the clinical laboratories have been evidently improved and the quality of kits has also been substantially improved.